{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:48:14Z","timestamp":1791402494682,"version":"4.3.3"},"reference-count":14,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,9,16]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>A 21-year-old G3P2011 Caucasian woman at 27 weeks\u2019 gestation presented with fetal tachyarrhythmia between 240 and 270 beats per minute. Fetal supraventricular tachycardia, abdominal ascites, pleural effusion and pericardial effusion indicated hydrops fetalis. Management with digoxin and flecainide converted the fetus to sinus rhythm and resolved the ascites and pleural effusion within 4\u2009days of treatment. Flecainide was discontinued at 31 weeks\u2019 gestation due to elevated liver enzymes. Intrahepatic cholestasis was treated with ursodiol. Caesarean section was performed at 37 weeks\u2019 gestation. Neonatal echocardiogram revealed a bicuspid aortic valve with mild regurgitation and a patent foramen ovale, and the infant showed no subsequent evidence of tachyarrhythmia or hydrops after delivery. Treatment of hydrops fetalis in the antenatal period is complex, and early diagnosis and treatment can quickly resolve supraventricular tachycardia-induced hydrops fetalis.<\/jats:p>","DOI":"10.1136\/bcr-2020-235827","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T14:25:18Z","timestamp":1602339918000},"page":"e235827","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Complete resolution of arrhythmia-induced hydrops fetalis in utero"],"prefix":"10.1136","volume":"13","author":[{"given":"Monisha","family":"Narayanan","sequence":"first","affiliation":[{"name":"Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sypara","family":"Dhuka","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilatha","family":"Alapati","sequence":"additional","affiliation":[{"name":"Pediatrics, Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3589-9979","authenticated-orcid":false,"given":"Robert P","family":"Kauffman","sequence":"additional","affiliation":[{"name":"OB-GYN, Texas Tech University Health Science Center School of Medicine, Amarillo, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,10]]},"reference":[{"key":"2025082708380005000_13.10.e235827.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2014.10.027"},{"key":"2025082708380005000_13.10.e235827.2","first-page":"26","article-title":"Non-Immune fetal hydrops: are we doing the appropriate tests each time?","volume":"1","author":"Kurdi","year":"2007","journal-title":"J Prenat Med"},{"key":"2025082708380005000_13.10.e235827.3","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases . LiverTox: clinical and research information on drug-induced liver injury. Bethesda, MD, 2012. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548023\/"},{"key":"2025082708380005000_13.10.e235827.4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/17512433.2017.1344096","article-title":"Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia","volume":"10","author":"Martin-Suarez","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025082708380005000_13.10.e235827.5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-123825"},{"key":"2025082708380005000_13.10.e235827.6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00246-017-1662-1","article-title":"Postnatal outcomes of fetal supraventricular tachycardia: a multicenter study","volume":"38","author":"Hinkle","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"2025082708380005000_13.10.e235827.7","doi-asserted-by":"publisher","DOI":"10.1159\/000151676"},{"key":"2025082708380005000_13.10.e235827.8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.64","article-title":"Fetal supraventricular tachycardia diagnosed and treated at 13 weeks of gestation: a case report","volume":"21","author":"Porat","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025082708380005000_13.10.e235827.9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.11152\/mu-1617","article-title":"Fetal supraventricular tachycardia at 12 weeks of gestation: diagnosis and follow up. A case report","volume":"21","author":"Bravo-Valenzuela","year":"2019","journal-title":"Med Ultrason"},{"key":"2025082708380005000_13.10.e235827.10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4103\/0019-5359.56117","article-title":"Prenatal management with digoxin and sotalol combination for fetal supraventricular tachycardia: case report and review of literature","volume":"63","author":"Suri","year":"2009","journal-title":"Indian J Med Sci"},{"key":"2025082708380005000_13.10.e235827.11","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008515","article-title":"Fetal supraventricular tachycardia, treating the baby by targeting the mother","volume":"2013","author":"Husain","year":"2013","journal-title":"BMJ Case Rep"},{"key":"2025082708380005000_13.10.e235827.12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1742-1241.2001.tb11125.x","article-title":"Supraventricular tachycardia with hydrops in a 27-week premature baby","volume":"55","author":"Abraham","year":"2001","journal-title":"Int J Clin Pract"},{"key":"2025082708380005000_13.10.e235827.13","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.hrthm.2016.03.023","article-title":"Flecainide versus digoxin for fetal supraventricular tachycardia: comparison of two drug treatment protocols","volume":"13","author":"Sridharan","year":"2016","journal-title":"Heart Rhythm"},{"key":"2025082708380005000_13.10.e235827.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.12.018"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-235827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:38:10Z","timestamp":1756309090000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-235827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":14,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,10]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/bcr-2020-235827"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-235827","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}